UA100377C2 - Antibodies against il-25 - Google Patents

Antibodies against il-25

Info

Publication number
UA100377C2
UA100377C2 UAA200911796A UAA200911796A UA100377C2 UA 100377 C2 UA100377 C2 UA 100377C2 UA A200911796 A UAA200911796 A UA A200911796A UA A200911796 A UAA200911796 A UA A200911796A UA 100377 C2 UA100377 C2 UA 100377C2
Authority
UA
Ukraine
Prior art keywords
antibody
treatment
relates
antibodies against
asthma
Prior art date
Application number
UAA200911796A
Other languages
English (en)
Ukrainian (uk)
Inventor
Andrew Neil James Mckenzie
Sarah Ballantyne
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of UA100377C2 publication Critical patent/UA100377C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200911796A 2007-04-18 2008-04-17 Antibodies against il-25 UA100377C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0707505.4A GB0707505D0 (en) 2007-04-18 2007-04-18 Antibodies against il-25

Publications (1)

Publication Number Publication Date
UA100377C2 true UA100377C2 (en) 2012-12-25

Family

ID=38135020

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200911796A UA100377C2 (en) 2007-04-18 2008-04-17 Antibodies against il-25

Country Status (32)

Country Link
US (1) US8206717B2 (ru)
EP (1) EP2144934B1 (ru)
JP (1) JP5366930B2 (ru)
KR (1) KR101605861B1 (ru)
CN (1) CN101711256B (ru)
AU (1) AU2008240436B2 (ru)
BR (1) BRPI0810418A8 (ru)
CA (1) CA2684492C (ru)
CO (1) CO6260104A2 (ru)
CR (1) CR11079A (ru)
CY (1) CY1118244T1 (ru)
DK (1) DK2144934T3 (ru)
EA (1) EA018073B1 (ru)
EC (1) ECSP099726A (ru)
ES (1) ES2604255T3 (ru)
GB (1) GB0707505D0 (ru)
GT (1) GT200900271A (ru)
HN (1) HN2009003038A (ru)
HR (1) HRP20161548T1 (ru)
HU (1) HUE030935T2 (ru)
IL (1) IL201552A (ru)
LT (1) LT2144934T (ru)
MX (1) MX2009011234A (ru)
MY (1) MY148451A (ru)
NI (1) NI200900189A (ru)
NZ (1) NZ581178A (ru)
PL (1) PL2144934T3 (ru)
PT (1) PT2144934T (ru)
RS (1) RS55401B1 (ru)
SI (1) SI2144934T1 (ru)
UA (1) UA100377C2 (ru)
WO (1) WO2008129263A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0817891D0 (en) * 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25
US8574582B2 (en) * 2008-10-31 2013-11-05 Janssen Biotech, Inc. Methods for mediating fibrotic response
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
EP2477647B1 (en) 2009-09-14 2016-01-13 The Regents of the University of Colorado Modulation of yeast-based immunotherapy products and responses
ES2656336T3 (es) 2010-03-30 2018-02-26 Janssen Biotech, Inc. Anticuerpos de IL-25 humanizados
WO2013119419A1 (en) * 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN103792375B (zh) * 2014-01-29 2017-07-07 华中科技大学同济医学院附属同济医院 外周血白细胞介素25水平在哮喘分型中的应用及分型方法
AU2015321517B2 (en) * 2014-09-23 2021-02-18 Regeneron Pharmaceuticals, Inc. Anti-IL-25 antibodies and uses thereof
WO2017160587A1 (en) * 2016-03-16 2017-09-21 Abeome Corporation Neutralizing monoclonal antibodies to il-25 and uses thereof
WO2018017864A2 (en) * 2016-07-20 2018-01-25 Oncomed Pharmaceuticals, Inc. Pvrig-binding agents and uses thereof
WO2018018082A1 (en) 2016-07-26 2018-02-01 The Australian National University Immunostimulatory compositions and uses therefor
EP3538558A4 (en) 2016-11-09 2020-07-15 North Carolina State University TREATMENT OF ALLERGIC DISEASES WITH A CHIMERAL PROTEIN
CN112638940B (zh) * 2018-11-19 2022-09-30 苏州鑫康合生物医药科技有限公司 抗-il-25抗体及其用途
GB202018015D0 (en) 2020-11-16 2020-12-30 Res & Innovation Uk Composition and methods for the treatment of intestinal cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
CN1289668C (zh) * 2003-06-12 2006-12-13 北京安波特基因工程技术有限公司 一种用于抗体改形的体外分子定向进化方法
ES2533970T3 (es) 2005-03-08 2015-04-16 Aptose Biosciences Inc. Uso de interleucina 17E para el tratamiento de cáncer
US20070237763A1 (en) 2005-10-06 2007-10-11 Baylor Research Institute Compositions and methods for the treatment of cancer
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25

Also Published As

Publication number Publication date
EA200901421A1 (ru) 2010-10-29
HRP20161548T1 (hr) 2016-12-30
SI2144934T1 (sl) 2016-12-30
GT200900271A (es) 2010-11-03
JP5366930B2 (ja) 2013-12-11
CA2684492C (en) 2015-11-24
DK2144934T3 (en) 2016-12-12
GB0707505D0 (en) 2007-05-30
EA018073B1 (ru) 2013-05-30
MY148451A (en) 2013-04-30
JP2010524450A (ja) 2010-07-22
HN2009003038A (es) 2011-11-11
RS55401B1 (sr) 2017-04-28
US8206717B2 (en) 2012-06-26
ES2604255T3 (es) 2017-03-06
PT2144934T (pt) 2016-12-02
AU2008240436B2 (en) 2011-03-17
IL201552A (en) 2015-08-31
CO6260104A2 (es) 2011-03-22
CY1118244T1 (el) 2017-06-28
EP2144934A1 (en) 2010-01-20
KR101605861B1 (ko) 2016-03-24
CN101711256A (zh) 2010-05-19
CA2684492A1 (en) 2008-10-30
ECSP099726A (es) 2010-01-29
EP2144934B1 (en) 2016-08-24
NZ581178A (en) 2012-01-12
KR20100021569A (ko) 2010-02-25
IL201552A0 (en) 2010-05-31
CN101711256B (zh) 2013-10-16
LT2144934T (lt) 2016-12-27
WO2008129263A1 (en) 2008-10-30
US20100129380A1 (en) 2010-05-27
AU2008240436A1 (en) 2008-10-30
MX2009011234A (es) 2010-02-18
NI200900189A (es) 2010-09-13
PL2144934T3 (pl) 2017-07-31
BRPI0810418A8 (pt) 2018-12-11
CR11079A (es) 2010-03-03
HUE030935T2 (en) 2017-06-28
BRPI0810418A2 (pt) 2014-10-14

Similar Documents

Publication Publication Date Title
UA100377C2 (en) Antibodies against il-25
UA95478C2 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТ с-Kit
UA116873C2 (uk) Антитіло, яке зв'язується з ox40
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
UA95068C2 (ru) Антиген-связующая молекула, которая связывает egfr, вектор, который ее кодирует, и их применение
UA115439C2 (uk) Гуманізоване антитіло, яке розпізнає альфа-синуклеїн
MX369148B (es) Agentes de unión kir3dl2.
UA114891C2 (uk) ІЗОЛЬОВАНЕ АНТИТІЛО ЛЮДИНИ, ЯКЕ СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З АНГІОПОЕТИНПОДІБНИМ БІЛКОМ 3 ЛЮДИНИ (hАNGPTL3), ТА ЙОГО ЗАСТОСУВАННЯ
UA115657C2 (uk) Виділене антитіло, яке зв'язується з одним або декількома епітопами тау, фармацевтична композиція, що його містить, спосіб лікування та спосіб діагностики хвороби альцгеймера на основі виділеного антитіла
PE20180480A1 (es) Anticuerpos de factor xi y metodos de uso
WO2008079246A3 (en) Cd44 antibodies
UA116194C2 (uk) Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном
UA115540C2 (uk) Антитіло до il-36r
EA201492101A1 (ru) Антитела против fcrn
MX2009003306A (es) Anticuerpos humanos que se unen a cxcr4 y sus usos.
WO2009112245A9 (en) Antibody against the csf-1 r
MX2010000537A (es) Anticuerpos monoclonales contra glipicano-3.
MX2009004532A (es) Composiciones y metodos para unir esfingosina-1-fosfato.
UA114902C2 (uk) Виділене антитіло, яке зв'язує парний спіральний філамент-тау (псф-тау), та фармацевтична композиція, що містить таке антитіло
PH12015501505B1 (en) Antibodies that bind to tl1a and their uses
IL212633A (en) A monoclonal antibody or its antigen-binding portion, its pharmaceutical preparations and its use in the preparation of cancer drugs
WO2008134659A3 (en) Antagonists to il-17a, il-17f, and il-23p19 and methods of use
MY150246A (en) Alpha 5 - beta 1 antibodies and their uses
CL2008003784A1 (es) Anticuerpo humanizado anti proteina e2 del virus de la hepatitis c o un fragmento de union; acido nucleico que lo codifica; vector y celula huesped que comprenden dicho acido nucleico; metodo para producir el anticuerpo; composicion farmaceutica que comprende el anticuerpo
CY1116313T1 (el) Αντισωματα εναντιον il-25